Aquestive Therapeutics
AQST
AQST
60 hedge funds and large institutions have $62M invested in Aquestive Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-3
Holders Change %
-4.76%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
11
Reduced
23
Closed
24
Calls
$592K
Puts
$428K
Net Calls
+$164K
Net Calls Change
+$430K
Top Buyers
1 |
Millennium Management
New York
|
+$1.74M |
2 |
Renaissance Technologies
New York
|
+$974K |
3 |
CCM
CAAS Capital Management
New York
|
+$862K |
4 |
Morgan Stanley
New York
|
+$777K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$753K |
Top Sellers
1 |
BlackRock
New York
|
-$3.99M |
2 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.97M |
3 |
State Street
Boston,
Massachusetts
|
-$1.01M |
4 |
Northern Trust
Chicago,
Illinois
|
-$665K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
-$536K |